Control Bionics Limited (ASX:CBL)

Australia flag Australia · Delayed Price · Currency is AUD
0.0300
-0.0010 (-3.23%)
May 30, 2025, 3:34 PM AEST
-30.23%
Market Cap 8.84M
Revenue (ttm) 5.28M
Net Income (ttm) -6.95M
Shares Out 294.61M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 46,576
Average Volume 101,730
Open 0.0300
Previous Close 0.0310
Day's Range 0.0300 - 0.0300
52-Week Range 0.0300 - 0.1050
Beta 0.07
RSI 29.56
Earnings Date May 26, 2025

About Control Bionics

Control Bionics Limited, together with its subsidiaries, engages in the research, development, commercialization, and sale of assistive communications technology systems in Australia, North America, and internationally. The company offers NeuroNode Trilogy, NeuroNode Duo, and Eye-gaze Duo systems that allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. It also provides Cosmos Connect, a small portable control device that ... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2005
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol CBL
Full Company Profile

Financial Performance

In 2024, Control Bionics's revenue was 5.35 million, a decrease of -5.17% compared to the previous year's 5.64 million. Losses were -5.91 million, 5.02% more than in 2023.

Financial Statements

News

There is no news available yet.